OPKO Health Total Assets 2010-2023 | OPK

OPKO Health total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
OPKO Health Annual Total Assets
(Millions of US $)
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
2010 $78
2009 $87
OPKO Health Quarterly Total Assets
(Millions of US $)
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
2010-12-31 $78
2010-09-30 $68
2010-06-30 $68
2010-03-31 $87
2009-12-31 $87
2009-09-30 $84
2009-06-30 $60
2009-03-31 $19
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.885B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.482B 26.59
Intuitive Surgical (ISRG) United States $131.844B 79.42
Edwards Lifesciences (EW) United States $50.799B 33.06
DexCom (DXCM) United States $50.060B 75.83
IQVIA Holdings (IQV) United States $42.279B 25.07
IDEXX Laboratories (IDXX) United States $38.873B 45.31
Alcon (ALC) Switzerland $38.723B 28.56
STERIS (STE) Ireland $20.261B 23.98
Waters (WAT) United States $18.737B 26.89
Hologic (HOLX) United States $17.905B 19.76
SONOVA HOLDING (SONVY) Switzerland $16.708B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $12.452B 15.38
ShockWave Medical (SWAV) United States $12.372B 85.23
Sysmex ADR (SSMXY) Japan $10.492B 32.90
Teleflex (TFX) United States $9.964B 15.65
Penumbra (PEN) United States $7.957B 98.22
Masimo (MASI) United States $7.091B 39.77
Globus Medical (GMED) United States $6.827B 21.64
Glaukos (GKOS) United States $4.964B 0.00
TransMedics (TMDX) United States $3.847B 367.50
Integer Holdings (ITGR) United States $3.678B 22.22
LivaNova (LIVN) United Kingdom $3.391B 20.14
PROCEPT BioRobotics (PRCT) United States $3.115B 0.00
Elekta AB (EKTAY) Sweden $2.700B 18.52
Nihon Kohden (NHNKY) Japan $2.423B 20.49
Inari Medical (NARI) United States $2.419B 0.00
Tandem Diabetes Care (TNDM) United States $2.337B 0.00
Integra LifeSciences Holdings (IART) United States $2.294B 9.41
RxSight (RXST) United States $2.108B 0.00
Alphatec Holdings (ATEC) United States $1.813B 0.00
Veracyte (VCYT) United States $1.539B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.868B 16.06
Artivion (AORT) United States $0.838B 96.81
Paragon 28 (FNA) United States $0.817B 0.00
Silk Road Medical (SILK) United States $0.795B 0.00
OrthoPediatrics (KIDS) United States $0.738B 0.00
Treace Medical Concepts (TMCI) United States $0.671B 0.00
SiBone (SIBN) United States $0.598B 0.00
Mesa Laboratories (MLAB) United States $0.594B 20.18
IRadimed (IRMD) United States $0.532B 30.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.487B 0.00
Pacific Biosciences Of California (PACB) United States $0.460B 0.00
Pulse Biosciences (PLSE) United States $0.420B 0.00
NeuroPace (NPCE) United States $0.401B 0.00
Nevro (NVRO) United States $0.382B 0.00
Tactile Systems Technology (TCMD) United States $0.341B 11.47
AxoGen (AXGN) United States $0.287B 0.00
Sight Sciences (SGHT) United States $0.277B 0.00
EDAP TMS S.A (EDAP) France $0.263B 0.00
AngioDynamics (ANGO) United States $0.232B 0.00
CVRx (CVRX) United States $0.219B 0.00
Accuray (ARAY) United States $0.215B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
908 Devices (MASS) United States $0.187B 0.00
Semler Scientific (SMLR) United States $0.184B 9.90
Alpha Tau Medical (DRTS) Israel $0.169B 0.00
Inogen (INGN) United States $0.166B 0.00
Delcath Systems (DCTH) United States $0.150B 0.00
ClearPoint Neuro (CLPT) United States $0.147B 0.00
Neuronetics (STIM) United States $0.107B 0.00
KORU Medical Systems (KRMD) United States $0.103B 0.00
Spectral Diagnostics (EDTXF) Canada $0.095B 0.00
Envoy Medical (COCH) United States $0.087B 0.00
EnVVeno Medical (NVNO) United States $0.068B 0.00
Autonomix Medical (AMIX) United States $0.063B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
Sensus Healthcare (SRTS) United States $0.059B 120.33
SEP Acquisition (SEPA) United States $0.058B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Yubo Biotech (YBGJ) China $0.053B 0.00
Vasomedical (VASO) United States $0.050B 9.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
InspireMD (NSPR) Israel $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.044B 0.00
DarioHealth (DRIO) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
Aspira Women's Health (AWH) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
LENSAR (LNSR) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
PAVmed (PAVM) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00